Evidence map›Paper›PMID 34866686›Full record

ArticleBulletin of the World Health Organization2021

Towards a universal understanding of post COVID-19 condition.

Janet V Diaz, Margaret Herridge, Silvia Bertagnolio, Hannah E Davis, Tarun Dua, Charu Kaushic, John C Marshall, Maria Del Rosario Pérez, Nathalie Strub-Wourgaft, Joan B Soriano

Abstract read
In one paragraph

Article in Bulletin of the World Health Organization, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Does post COVID-19 characterize new diseases and disabilities?The Lancet regional health. Southeast Asia · 2023
    Article
  5. Article
  6. Observational
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Janet V DiazClinical Management Team, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland.
Margaret HerridgeDepartment of Medicine, Interdepartmental Division of Critical Care, University of Toronto, Toronto, Canada.
Silvia BertagnolioDepartment of Control, Surveillance and Prevention of Antimicrobial Resistance, World Health Organization, Geneva, Switzerland.
Hannah E DavisPatient-Led Research Collaborative, United States of America.
Tarun DuaBrain Health Unit, World Health Organization, Geneva, Switzerland.
Charu KaushicCIHR Institute of Infection and Immunity, McMaster University, Hamilton, Canada.
John C MarshallDepartments of Surgery and Critical Care Medicine, St Michael's Hospital, Toronto, Canada.
Maria Del Rosario PérezClinical Management Team, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland.
Nathalie Strub-WourgaftDrugs for Neglected Diseases initiative, Geneva, Switzerland.
Joan B SorianoClinical Management Team, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland.

Funding

World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19HumansSARS-CoV-2

Identifiers

PMID34866686
PMCPMC8640686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.